Document Detail


Oncosuppressive role of p53-induced miR-205 in triple negative breast cancer.
MedLine Citation:
PMID:  22578566     Owner:  NLM     Status:  MEDLINE    
Abstract/OtherAbstract:
An increasing body of evidence highlights an intriguing interaction between microRNAs and transcriptional factors involved in determining cell fate, including the well known "genome guardian" p53. Here we show that miR-205, oncosuppressive microRNA lost in breast cancer, is directly transactivated by oncosuppressor p53. Moreover, evaluating miR-205 expression in a panel of cell lines belonging to the highly aggressive triple negative breast cancer (TNBC) subtype, which still lacks an effective targeted therapy and characterized by an extremely undifferentiated and mesenchymal phenotype, we demonstrated that this microRNA is critically down-expressed compared to a normal-like cell line. Re-expression of miR-205 where absent strongly reduces cell proliferation, cell cycle progression and clonogenic potential in vitro, and inhibits tumor growth in vivo, and this tumor suppressor activity is at least partially exerted through targeting of E2F1, master regulator of cell cycle progression, and LAMC1, component of extracellular matrix involved in cell adhesion, proliferation and migration.
Authors:
Claudia Piovan; Dario Palmieri; Gianpiero Di Leva; Luca Braccioli; Patrizia Casalini; Gerard Nuovo; Monica Tortoreto; Marianna Sasso; Ilaria Plantamura; Tiziana Triulzi; Cristian Taccioli; Elda Tagliabue; Marilena V Iorio; Carlo M Croce
Related Documents :
9413616 - Hplc/circular dichroism detection using a split-type flow cell for polarized photometri...
22694196 - The inhibitory effects and mechanisms of rhamnogalacturonan i pectin from potato on ht-...
18369326 - Cell vehicle targeting strategies.
20466156 - In vitro assays to study force generation at dynamic microtubule ends.
19762996 - Bacterial cell surface display: a method for studying japanese encephalitis virus patho...
2846786 - Comparison of the effects of forskolin and dibutyryl cyclic amp in neuroblastoma cells:...
Publication Detail:
Type:  Journal Article; Research Support, Non-U.S. Gov't     Date:  2012-04-19
Journal Detail:
Title:  Molecular oncology     Volume:  6     ISSN:  1878-0261     ISO Abbreviation:  Mol Oncol     Publication Date:  2012 Aug 
Date Detail:
Created Date:  2012-07-30     Completed Date:  2013-03-18     Revised Date:  2013-06-25    
Medline Journal Info:
Nlm Unique ID:  101308230     Medline TA:  Mol Oncol     Country:  Netherlands    
Other Details:
Languages:  eng     Pagination:  458-72     Citation Subset:  IM    
Copyright Information:
Published by Elsevier B.V.
Affiliation:
Departments of Molecular Virology, Immunology and Human Genetics, Comprehensive Cancer Center, Ohio State University, Columbus, OH 43210, USA.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:
Animals
Base Sequence
Breast Neoplasms / genetics*,  pathology
Cell Aging / genetics
Cell Cycle / genetics
Cell Line, Tumor
Cell Proliferation
Down-Regulation / genetics
E2F1 Transcription Factor / metabolism
Female
Gene Expression Regulation, Neoplastic
Humans
Laminin / metabolism
Mice
Mice, SCID
MicroRNAs / genetics*,  metabolism
Molecular Sequence Data
Protein Binding
Response Elements / genetics
Transcription, Genetic
Tumor Suppressor Protein p53 / metabolism*
Xenograft Model Antitumor Assays
Grant Support
ID/Acronym/Agency:
U01 CA152758/CA/NCI NIH HHS
Chemical
Reg. No./Substance:
0/E2F1 Transcription Factor; 0/E2F1 protein, human; 0/Laminin; 0/MIRN205 microRNA, human; 0/MicroRNAs; 0/Tumor Suppressor Protein p53; 0/laminin gamma 1
Comments/Corrections

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  P16 expression predicts necrotic response among patients with osteosarcoma receiving neoadjuvant che...
Next Document:  Strategies for surgically assisted rapid maxillary expansion according to the region of transverse m...